Biocius Life Sciences Inc., a Wakefield spectrometry device maker, has been bought by Agilent Technologies Inc., the California company announced today.
Agilent (NYSE: A) is a measurement company that focuses on chemical analysis, life sciences and electronic measurement.
No financial terms of the acquisition were disclosed, but the news release indicates that Biocius’ 25 employees have joined Agilent.
Biocius makes a spectrometry-based drug discovery screening device, called RapidFire, that is intended to make drug discovery more efficient for researchers.
Biocius was spun out from Woburn-based BioTrove Inc. in December 2009, and was co-located with its parent until it moved to another location in Woburn a month after its formation. The company was spun out to hold BioTrove’s RapidFire intellectual property separate from Carlsbad, Calif.-based Life Technologies Corp. (Nasdaq: LIFE), which acquired BioTrove in 2009.
The privately held company experienced a growth spurt in 2010, relocating its headquarters to Wakefield’s larger facility and opening a European office near Geneva, Switzerland.
